Medicalg (MDG) — Capital Reinvestment Ratio

Latest as of March 2026: 3.25x

Medicalg (MDG) has a Capital Reinvestment Ratio of 3.25x as of March 2026, meaning it reinvests 3% of its operating cash flow (zł1.18 Million) in capital expenditures (zł3.83 Million). See Medicalg free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

3.25x
Capex / Operating Cash Flow

Operating Cash Flow

zł1.18 Million
PLN

Capital Expenditures

zł3.83 Million
PLN

Data as of

Mar 2026
Most recent filing

Medicalg Capital Reinvestment Ratio (2011–2023)

This chart tracks Medicalg's Capital Reinvestment Ratio across 10 annual periods.

Annual Capital Reinvestment Ratio for Medicalg (2011–2023)

Year-by-year Capital Reinvestment Ratio for Medicalg from 2011 to 2023. For live market cap and broader valuation context, see MDG company net worth.

Year Reinvestment Ratio Operating CF (PLN) Capital Expenditures YoY Change
2023 62.19x zł182.00K zł11.32 Million ▲ +3082.0%
2022 1.95x zł6.33 Million zł12.37 Million ▲ +201.7%
2019 0.65x zł13.50 Million zł8.74 Million ▲ +345.4%
2018 0.15x zł44.23 Million zł6.43 Million ▼ -89.0%
2017 1.32x zł28.61 Million zł37.83 Million ▲ +452.7%
2016 0.24x zł35.48 Million zł8.49 Million ▲ +54.1%
2015 0.16x zł17.35 Million zł2.69 Million ▲ +278.1%
2013 0.04x zł5.58 Million zł229.00K ▼ -18.0%
2012 0.05x zł4.11 Million zł205.84K ▼ -85.6%
2011 0.35x zł2.69 Million zł933.56K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow